Table of Contents
Antiemetics are medications used to prevent or treat nausea and vomiting, which are common side effects of cancer treatments such as chemotherapy, radiation therapy, and surgery. Understanding the pharmacology of these agents is essential for effective management and improving patient quality of life.
Overview of Antiemetics in Cancer Care
The selection of antiemetics depends on the type and timing of cancer treatment, as well as patient-specific factors. They can be classified based on their mechanism of action and include several drug classes.
Major Classes of Antiemetics
- Serotonin (5-HT3) receptor antagonists
- Neurokinin-1 (NK1) receptor antagonists
- Corticosteroids
- Antihistamines
- Anticholinergics
- Dopamine receptor antagonists
Serotonin (5-HT3) Receptor Antagonists
This class includes drugs such as ondansetron, granisetron, and palonosetron. They block serotonin receptors in the central nervous system and gastrointestinal tract, effectively preventing nausea caused by chemotherapy.
Pharmacology
5-HT3 antagonists are selective serotonin receptor blockers that inhibit the emetic signaling pathway. They have a rapid onset and are well-tolerated, with common side effects including headache and constipation.
Neurokinin-1 (NK1) Receptor Antagonists
Examples include aprepitant, fosaprepitant, and rolapitant. These drugs block NK1 receptors in the brain, reducing nausea and vomiting associated with delayed chemotherapy-induced emesis.
Pharmacology
NK1 antagonists inhibit substance P from binding to NK1 receptors, disrupting the emetic pathway. They are often used in combination with 5-HT3 antagonists and corticosteroids for enhanced efficacy.
Corticosteroids
Dexamethasone and methylprednisolone are commonly used corticosteroids with antiemetic properties. They are effective in combination therapy for chemotherapy-induced nausea.
Pharmacology
Corticosteroids modulate inflammation and may influence neurotransmitter pathways involved in nausea. Their exact mechanism in antiemesis remains unclear but is believed to involve central and peripheral actions.
Antihistamines and Anticholinergics
Diphenhydramine, hydroxyzine, and scopolamine are examples used mainly for motion sickness and postoperative nausea. They block histamine and acetylcholine receptors, respectively.
Pharmacology
These agents inhibit signals from the vestibular system and inner ear, reducing nausea related to motion or vestibular disturbances. Side effects include sedation and dry mouth.
Dopamine Receptor Antagonists
Metoclopramide and prochlorperazine are common drugs in this class. They block dopamine receptors in the chemoreceptor trigger zone (CTZ) of the brain.
Pharmacology
These agents enhance gastrointestinal motility and suppress nausea signals. Their use is limited by side effects such as extrapyramidal symptoms and sedation.
Conclusion
The pharmacology of antiemetics in cancer care involves multiple drug classes targeting different pathways involved in nausea and vomiting. Combining agents from various classes often provides the most effective control, tailored to individual patient needs.